Mild behavioral impairment in people with mild cognitive impairment: Are the two conditions related?

Julia-Sophia Scheuermann1, Elmar Graessel1, André Kratzer1

  • 1Center for Health Services Research in Medicine, Department of Psychiatry and Psychotherapy, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

PubMed
Abstract

Insights

Mild cognitive impairment (MCI) and mild behavioral impairment (MBI) are linked, especially in individuals with lower cognitive scores. A specific Montreal Cognitive Assessment (MoCA) threshold is needed to detect this association in dementia prodromal stages.

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychiatry

Background:

  • Mild cognitive impairment (MCI) and mild behavioral impairment (MBI) are potential early indicators of dementia, particularly Alzheimer's disease.
  • Limited research exists on MBI in MCI patients and their interconnectedness.

Purpose of the Study:

  • To explore associations between MBI aspects and cognitive performance dimensions measured by the Montreal Cognitive Assessment (MoCA).

Main Methods:

  • Utilized baseline data from the MCI-CCT-study, assessing MCI with MoCA and MBI via self-report (MBI short scale).
  • Employed Pearson correlations, sensitivity analyses for gender and cognition, and logistic regressions.

Main Results:

  • No overall correlation between MoCA and MBI short scores was found in the total sample.
  • Significant correlations emerged when cognitive performance was dichotomized, particularly in individuals with lower MoCA scores.
  • Task-level analyses revealed significant associations between specific MoCA and MBI dimensions, even after covariate control.

Conclusions:

  • The link between MCI and MBI strengthens as cognitive decline progresses.
  • A specific MoCA score threshold is required to observe a significant correlation between MCI and MBI.

Related Concept Videos

Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
42
Language and Cognition01:27

Language and Cognition

Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
325
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
58
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
98
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
44